SCHEMBL5574246

SCHEMBL5574246

CC#COCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570484 0.75
Bicarbonate SCHEMBL31496486 0.74 ALDH1A1 (0.33)
SCHEMBL1100317 0.69
SCHEMBL15632758 0.67
SCHEMBL6552793 0.67
SCHEMBL6960246 0.65
SCHEMBL15234346 0.65 PAM (0.36)
Methoxyacetic Acid SCHEMBL27704436 0.63
SCHEMBL6847839 0.63
SCHEMBL4159095 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114128-B1 NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2019-01-02 EP claimed
EP-1347780-B1 COMPOSITIONS OF N-(METHYLETHYLAMINOCARBONYL)-4-(3-METHYLPHENYLAMINO)-3-PYRIDYLSULFONAMIDE AND CYCLIC OLIGOSACCHARIDES PLIVA PHARM & CHEM WORKS (HR) 2007-01-03 EP claimed